Chronic Systemic Inflammatory Syndrome in patients with AECOPD presenting to Emergency Department

Piras, O.; Travaglino, F.; Autunno, A.; Bresciani, E.; Della Corte, A.; Lalle, I.; Di Somma, Salvatore
January 2012
European Review for Medical & Pharmacological Sciences;2012 Supplement, Vol. 16, p57
Academic Journal
Background: Chronic obstructive pulmonary disease (COPD) is the fourth cause of dead in the world. Because of high incidence of comorbidities in COPD patients, it has been proposed a new hypothesis that inscribe this disease in a complex contest named Chronic Systemic Inflammatory Syndrome (CSIS). Either COPD and the most common comorbidities responsible for its clinical and natural history, like hypertension, diabetes, coronary artery disease, heart failure, recognize a pro-inflammatory state, marked, for example, by elevated C reactive protein (CRP). Methods: 113 consecutive patients presenting to Emergency Department (ED) with acute exacerbated COPD were enrolled. They underwent to full medical history and physical examination. CRP was measured at ED arrival, discharge and at 1-6-12 month follow up. CSIS was diagnosed according to specified criteria. Results: CSIS was diagnosed in 84% patients. CRP was maximally increased at admission during the exacerbation, but didn't correlate with the severity of it. At discharge, CRP values were lowest; during follow up, CRP demonstrated a chaotic behavior growing up till 6 month without any correlation with new exacerbation events. At 1 year it decreased, never reaching normal values in the majority of our patients thus confirming the presence of a persistent inflammation in COPD. Conclusions: CSIS was diagnosed in 84% of our population demonstrating that COPD patients need to be approached in a multidisciplinary way.


Related Articles

  • Review of COPD and comorbidities. Dahlan, Zulkarnain // Critical Care & Shock;Aug2012, Vol. 15 Issue 3, p73 

    The article discusses on Chronic Obstructive Pulmonary Disease (COPD) and comorbidities, two or more diseases existing at the same time in the body. The author explains on the presence of comorbidities in people suffering from this disease. The management of this disease is also explained in...

  • Comorbidities Increase Death Rate for COPD Patients.  // AARC Times;Aug2012, Vol. 36 Issue 8, p61 

    The article reports a study by Miguel Divo that comorbidities are common and increase the rate of death among patients with chronic obstructive pulmonary disorder (COPD), including congestive heart failure, coronary artery disease, liver cirrhosis, diabetes with neuropathy, and cancer.

  • American Thoracic Society Intl Conference: Comorbidities are common in patients with COPD.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article offers information on a study which reveals that multiple extra-pulmonary comorbidities are present in the patients suffering with chronic obstructive pulmonary disease (COPD).

  • Patient preferences for asthma therapy: a discrete choice experiment. Lloyd, Andrew; McIntosh, Emma; Rabe, Klaus F.; Williams, Angela // Primary Care Respiratory Journal;Aug2007, Vol. 16 Issue 4, p241 

    Aim: This study was designed to capture patient preferences for different aspects of asthma treatment from people with asthma in the UK, the Netherlands and Spain. Methods: Asthma patients from the UK (n=124), the Netherlands (n=269) and Spain (n=86) participated in the survey. Patients'...

  • COPD Comorbidities Can Identify Mortality Risk. Baney, Jack // Pulmonary Reviews;Aug2012, Vol. 17 Issue 7, p12 

    The article reports on the identification of 12 co-morbidities that increase risks in patients with chronic obstructive pulmonary disease (COPD). Doctor Miguel Divo of Brigham and Women's Hospital and his colleagues investigated patients with COPD in the U.S. and Spain. Co-morbidities were...

  • COPD + Allergies = Trouble.  // AARC Times;Aug2013, Vol. 37 Issue 8, p57 

    The article reports on the findings of a study conducted by researchers at the Johns Hopkins Asthma and Allergy Center which investigated the impact of allergic phenotype and allergic sensitization in chronic obstructive pulmonary disease (COPD) patient. The results reveal that allergic disease...

  • Alteraciones endocrinometabólicas en la enfermedad pulmonar obstructiva crónica. Torres-Sánchez, Irene; Valenza, Marie Carmen; Carrasco, Fernando; Cabrera-Martos, Irene; Valenza-Demet, Gerald; Cano-Capellaci, Marcelo // Nutricion Hospitalaria;jul/ago2013, Vol. 28 Issue 4, p1022 

    Introduction: Chronic obstructive pulmonary disease (COPD) is characterized by the presence of chronic airflow obstruction and associated endocrinometabolic disorders, which usually worsen the clinic and prognostic of the patients. Therefore, in-depth knowledge of these prevalent disorders in...

  • Parsing the death toll of COPD.  // Clinical Oncology Alert;Oct2010 Supplement, p19 

    No abstract available.

  • Parsing the death toll of COPD. Kuritzky, Louis // Clinical Cardiology Alert;Oct2010 Pharmacology, p19 

    The article discusses research study on mortality rate of chronic obstructive pulmonary disease (COPD), which references a study by B. Zvezdin et el, published in a 2009 issue of "Chest."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics